NEWAMSTERDAM PHARMA COMPANY N.V.

Insiders NewAmsterdam Pharma Company N.V. Börse Stuttgart

Equities

KH6

NL00150012L7

Market Closed - Börse Stuttgart Other stock markets 07:04:53 05/07/2024 BST			5-day change	1st Jan Change
18.1 ^EUR	-0.55%		+1.12%	+82.83%

06-11	NewAmsterdam Pharma Gets Another US Patent Extending IP Protection for Obicetrapib Until July 2043	MT
06-10	Transcript : NewAmsterdam Pharma Company N.V. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-10-2024 10:40 AM

Insiders

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

NewAmsterdam Pharma Names Juliette Audet Chief Business Officer	04-01	MT
Newamsterdam Pharma Announces the Appointment of Juliette Audet as Chief Business Officer	04-01	CI
Newamsterdam Pharma Insider Sold Shares Worth $4,095,234, According to a Recent SEC Filing	03-27	MT
NewAmsterdam Pharma Company N.V. Announces Board Changes	01-08	CI
NewAmsterdam Pharma Appoints Ian Somaiya as Chief Financial Officer	23/10/23	MT
NewAmsterdam Pharma Company N.V. Appoints William ?BJ" Jones as Chief Commercial Officer	14/08/23	CI
NewAmsterdam Pharma Company Appoints Janneke van der Kamp to its Board of Directors	03/04/23	CI
NewAmsterdam Pharma Company N.V. Appoints John W. Smither as Independent Director	06/02/23	CI
NewAmsterdam Pharma Names David Topper CFO	19/12/22	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Secure my Investments

fermer